Aims: Zotarolimus-eluting stents (ZESs) have been shown to be safe and effective in randomised trials. We sought to report the clinical outcomes after implantation of ZES in real-world clin
1. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore; 2. The Heart Institute, National University Hospital, Singapore; 3. Center for Molecular Epidemiology and Department of Community, Occupational and Family Medici
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
clinical researchzotarolimuspolymerrestenosisstent thrombosis
Read next article"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents